GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CBNK · Dec 31, 2025

Capital Bancorp Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001419536-26-000073Bank
Sequential deposit growth85thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

6.22% · CORE · VALID

Net-income growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

84.59% · CORE · VALID

Interest-income growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

22.30% · CORE · VALID

Cash and equivalents70thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$255.6M · CORE · VALID

Sequential loan growth78thOwn-history percentile · N=18
Evidence method

Sequential · gp.financial.loans

4.91% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-0.98%
Current
6.22%
Delta
7.20%
Earnings Growth Increased
Previous
73.72%
Current
84.59%
Delta
10.87%
Interest Income Growth Decreased
Previous
23.34%
Current
22.30%
Delta
-1.04%
Liquidity Increased
Previous
$188.9M
Current
$255.6M
Delta
$66.7M
Loan Growth Increased
Previous
2.84%
Current
4.91%
Delta
2.06%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.